Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX – Get Free Report)’s stock price gapped up before the market opened on Monday . The stock had previously closed at $15.76, but opened at $16.68. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $16.68, with a volume of 375 shares changing hands.
Wall Street Analyst Weigh In
A number of research analysts have commented on the company. William Blair raised Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research report on Tuesday, November 19th. UBS Group began coverage on Telix Pharmaceuticals Limited American Depositary Shares in a report on Friday, November 15th. They set a “buy” rating and a $21.00 target price for the company.
Telix Pharmaceuticals Limited American Depositary Shares Stock Up 0.4 %
About Telix Pharmaceuticals Limited American Depositary Shares
Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.
Featured Articles
- Five stocks we like better than Telix Pharmaceuticals Limited American Depositary Shares
- P/E Ratio Calculation: How to Assess Stocks
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- Best Stocks Under $5.00
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- 3 Healthcare Dividend Stocks to Buy
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for Telix Pharmaceuticals Limited American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telix Pharmaceuticals Limited American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.
